This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example content
Adverse event reporting can be found at the bottom of the page
Prescribing information can be found at the bottom of the page.
Join us on 9 October 2024 to hear from Dr Tom Waddell, Consultant Medical Oncologist, Joseph Williams, Specialist Cancer and Lead Homecare Pharmacist, Professor Galina Velikova, Professor of Psychosocial & Medical Oncology, discussing 'National Renal Forum and Service Enhancement' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.
Prescribing information can be found at the bottom of the page.
Join us on 9 October 2024 to hear from Dr Tom Waddell, Consultant Medical Oncologist, Joseph Williams, Specialist Cancer and Lead Homecare Pharmacist, Professor Galina Velikova, Professor of Psychosocial & Medical Oncology, discussing 'National Renal Forum and Service Enhancement' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.
Joseph is a Specialist Cancer and Homecare Pharmacist at The Christie NHS Foundation Trust and has previously been a member of the Cancer team at Royal Manchester Children’s Hospital (RMCH) and University College London Hospitals NHS Foundation Trust (UCLH) with a specialist interest in colorectal cancer, prostate cancer, paediatrics and antimicrobial stewardship. He is also an independent prescriber within the colorectal cancer specialty.
Joseph is also an Honorary Clinical Lecturer in the Division of Pharmacy & Optometry at the University of Manchester (UoM) where he teaches a variety of topics including Cancer for Undergraduates and Postgraduates.
Joseph’s background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. He has also been fortunate to have had many opportunities to work with students in Higher Education Institutions around the country and has always been passionate about supporting students and teaching. Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.
No Biography Available
Professor Galina Velikova leads a clinical research group in Leeds Institute for Medical Research at St James’s to study the implementation of routine measurement of patient-reported outcomes and quality of life in oncology practice.
With programmatic funding from the National Institute for Health Research of England, Professor Velikova researches the use of online patient self-reporting of adverse events during and after treatment with chemotherapy and radiotherapy. The self-reported adverse events are integrated and displayed within the Electronic Patient Records to support immediate patient care. This work was recognised in 2014 by The Times Higher Education as one of “20 New Ideas from UK Universities that will Change the World”.
Professor Velikova leads the Quality of Life sub-studies of national and international clinical trials in Breast Cancer. Nationally, she is the academic lead of the NHS Quality of Life metric initiative, aiming to implement routine quality of life measurement for cancer patients and survivors after treatment as a tool to drive care quality improvements.
Inlyta®(axitinib)
Sutent®(sunitinib malate)
Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024